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Introduction (1)
Heritable alterations that are not due to changes in DNA sequence
Alter DNA accessibility and chromatin structure 
Regulate patterns of gene expression
Crucial for normal development and differentiation
Crucial for regulation of pluripotency genes
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Epigenetic mechanisms
Gene Expression
RNA Interference
DNA MethylationHistone Modifications
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 The basic repeating unit of 
chromatin.
 It is made up by five histone 
proteins: H2A, H2B, H3, H4 as 
core histones and H1 as a linker.
 It provides the lowest level of 
compaction of double-strand DNA 
into the cell nucleus.
 It often associates with 
transcription. 
Nucleosome
H2A H2B
H3
H4
1974: Roger Kornberg discovers nucleosome who won Nobel Prize in 2006.
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Latham and Dent
Nat Struct Mol Biol 2007
Histone modifications matter
Histone tails are modified, this influences
accessibility of the genomic DNA 
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Structure & Epigenetics of Euchromatin versus 
Heterochromatin 
Paula Vertino, Henry Stewart Talks
Me
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Histon modifying enzymes
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(3)
Effector proteins
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(3)
Histone acetylation
http://porpax.bio.miami.edu/~cmallery/150/gene/c7.19.4.histone.mod.jpg
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Other nuclear proteins crucial for epigenetic 
modifications 
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DNA methylation & Epigenetic (3)
In mammalian genome methylation occurs in C5
Methylation patterns are stable and inheritable
Reproramming occurs in 2 developmental stages
DNMT3A  and DNMTB are denovo methyltransferases
DNMT1s are maintenance methyltransferases
14
Other DNMTS (3)
Unlike DNMT1 & DNMT3A/B , DNMT2 has only catalytic domain
DNMTL expresses only in germ cell for de novo methylation
DNMTL modulates the catalytic activity of DNMT3A & DNM3TB
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Maintenance of
Cytosine Methylation
Alex Meissner, Henry Stewart TalksAlex Meissner, Henry Stewart Talks
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Passive Demethylation of
5-Methyl-Cytosine
Alex Meissner, Henry Stewart TalksAlex Meissner, Henry Stewart Talks
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Establishment and Maintenance of
Cytosine Methylation
Alex Meissner, Henry Stewart Talks
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http://www.nature.com/nbt/journal/v28/n10/fig_ta
b/nbt.1685_F1.html
Regions of DNA methylation
19
RNA Interference (RNAi)
http://www.nature.com/ncpneuro/journal/v3/n7/images/ncpneuro0551-f1.jpg
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(4)
Wnt signaling pathway (5)
Conserved pathway that has crucial regulation role
Cell fate determination , cell migration , cell polarity , neural patterning and 
organogenesis during embryonic development
Require for adult tissue maintenance
Perturbations in it promote both human degenerative diseases and cancer
Theraputic reagents are aimed for controlling wnt signaling
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Wnt signaling pathway
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Wnt signaling pathway & Epigenetic (6) 
Activation of wnt signaling pathway in the leukemia
The promoter methylation status of wnt antagonists ( sFRP 2,4,5 & DKK1,3) has 
been analyzed
Aberrant methylation of them was detected  by MSP ( methylation-specific 
polymerase chain reaction )
Function of epigenetic regulation of wnt pathway in predicting relapse in a 
subgroup of AML
23
Msp analysis in AML (acute myeloid leukemia) cell lines (6)
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Jak-stat signaling pathway (7)
Regulates embryonic development 
In the control of  processes such as stem cell maintenance , haematopoiesis & 
inflammatory response
Aberrant activation confers malignant properties on cancer cells
A productive strategy for drug development
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JAK/STAT Pathway
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Jak/STAT signaling pathway  &  epigenetic (8)
SOCS1 and SHP1 negatively regulate Jak/STAT signaling pathway
promoter hypermethylation is investigated in myeloma 
SHP1 : primarily express in hematopoietic cells  & is tumor suppressor gene 
Socs1 : cytokine-inducible negative regulators of the cytokine signaling                                  
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Epigenetic role on integral proteins (9)
Occludin is the first identified integral protein for 
tight junction (tj)
 Its long COOH-terminal domain receive and 
transmit cell survival signal
 Loss of tj –associated molecules correlate with 
tumor progression 
Occludin expression is silenced by CpG island 
hypermethylation
 Forced expression of occludin in cancer cells leads 
to acting apoptogenic factors
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Epigenetic & apoptosis (10)
Some hematopoietic disease (CLL) fails apopotosis B-cell
Nuclear factor kB ( NFkB) mediated expression of antiapoptotic molecules
Glycogen synthase kinase-3B (GSK3B) regulates (NFkB) 
They accumulate in the nucleus of CLL B cells
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Epigenetic & apoptosis
Pharmacologic inhibition of GSK-3 leads 
to decrease expression of Bcl-2 & XIAP
Abrogating binding is through an 
epigenetic mechanism
GSK-3 is a potential therapeutic target in 
the treatment of CLL
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Epigenetic & X-chromosome Inactivation
Source: Jones et al. Nat.Genet. 19, 187 (1998)
 In X-inactivation (lyonization) one of the two copies of the X 
chromosome present in female mammals is inactivated. 
 The inactive X chromosome is silenced by packaging in repressive 
heterochromatin. 
 The choice of which X chromosome will be inactivated is random .
 Silencing initiated at Xic/XIC and spreads along chromososme. 
 5meC CpG DNA modification is observed in inactivated X 
chromosomes.
 5meC binds transcriptional repressor MeCP2 (MethylC-binding 
Protein-2).
 MeCP2 binds Sin3 with RPD3 histone deacetylase.
transcriptional repressor
Histone Deacetylase
Sin3
RPD3
MeCP2
5’..pCpGp..3’
me
5
 3’..pGpCp..5’
5
me
co-repressor
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Differences in the epigenome of monozygotic twins
Fraga et al. PNAS, 2005
The difference in the twins’ epigenomes is what makes 
them become different when they are older
The epigenetic tags can have such an effect on the 
twins that one can develop a disease while the other is 
fine
When this situation occurs, researchers will try to 
pinpoint the environmental factors that are 
responsible for the disease
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conclusion
that differing amounts in methylation can play a role in an animal’s behavior
Failures in epigenetic are likely to play a role in the majority of cancer
Since most of the studies on epigenetics have been conducted on rodents, it will be 
interesting to see if their conclusions carry over into humans
33
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